OR WAIT null SECS
February 02, 2020
Data management is crucial in bio/pharmaceutical laboratory settings from discovery steps through clinical studies and varies based on the development phase.
Analytical solutions are improving for raw material testing, drug product release process development, and more.
Complex protein structures pose analytical challenges that can be addressed by advanced mass spectrometry technologies and workflows, which can be used to comprehensively characterize them.
January 31, 2020
The partners will collaborate on developing scale-up chip-based technology to enable commercial-scale production of a third-generation DNA synthesis platform.
The license gives Daiichi Sankyo access to ERS Genomics’ genome-editing technology for internal R&D initiatives.
The company’s new Milliflex Oasis System provides enhanced result reliability, increased productivity, and advanced traceability.
Otsuka will use PhoreMost’s phenotypic screening platform to identify new targets for drug development, with a focus on gene therapy.
January 06, 2020
The Ireland-based company can now offer complete elemental impurities testing services.
The new GMP conditioning product offering is designed to support clinical phase and commercialization stages of cell and gene therapy production.
December 15, 2019
Long a staple for quality by design and solid dosage form manufacturing, design of experiments is becoming an integral part of biopharma upstream process development.